Key facts
- This page summarizes Markus Sieger's Form 4 filing for Cyclo Therapeutics, Inc. (CYTH).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 24 Apr 2023, 10:27.
Markus Sieger - 20 Apr 2023 Form 4 Insider Report for Cyclo Therapeutics, Inc. (CYTH)
- Reporting relationship
- Director
- Issuer ticker
- CYTH
- Reported as of
- 20 Apr 2023
- Net transaction value
- +$50,001
- SEC form
- 4
- Accepted by SEC
- 24 Apr 2023, 10:27:56 UTC
- Prior SEC filing
- 09 Mar 2023
- Next SEC filing
- 18 May 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Markus Sieger
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Markus Sieger filed Form 4 for Cyclo Therapeutics, Inc. (CYTH) on 24 Apr 2023.
Change
- Previous filing in this sequence was filed on 09 Mar 2023.
- Current net transaction value: +$50,001.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CYTH
transaction
Common Stock
Purchase
- Transaction value
- $42,516
- Shares
- +59,881
- Change %
- +59%
- Price
- $0.7100
- Shares after
- 161,051
- Date
- 20 Apr 2023
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CYTH
transaction
Derivative
Warrant to Purchase Common Stock
Purchase
- Transaction value
- $7,485
- Shares
- +59,881
- Change %
- Price
- $0.1250*
- Shares after
- 59,881
- Date
- 20 Apr 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 59,881
- Exercise price
- $0.7100
* marks a reported price that did not pass the local price check.